| [1] |
González-Castejón M, Visioli F, Rodriguez-Casado A. 2012. Diverse biological activities of dandelion. |
| [2] |
Ivanov I, Petkova N, Tumbarski J, Dincheva I, Badjakov I, et al. 2018. GC-MS characterization of n-hexane soluble fraction from dandelion (Taraxacum officinale Weber ex F. H. Wigg. ) aerial parts and its antioxidant and antimicrobial properties. |
| [3] |
Davaatseren M, Hur HJ, Yang HJ, Hwang JT, Park JH, et al. 2013. Taraxacum official (dandelion) leaf extract alleviates high-fat diet-induced nonalcoholic fatty liver. |
| [4] |
Guo H, Zhang W, Jiang Y, Wang H, Chen G, et al. 2019. Physicochemical, structural, and biological properties of polysaccharides from dandelion. |
| [5] |
Lis B, Rolnik A, Jedrejek D, Soluch A, Stochmal A, et al. 2019. Dandelion (Taraxacum officinale L.) root components exhibit anti-oxidative and antiplatelet action in an in vitro study. |
| [6] |
Tanasa Acretei MV, Negreanu-Pirjol T, Olariu L, Negreanu-Pirjol BS, Lepadatu AC, et al. 2025. Bioactive compounds from vegetal organs of Taraxacum species (dandelion) with biomedical applications: a review. |
| [7] |
Xue Y, Zhang S, Du M, Zhu MJ. 2017. Dandelion extract suppresses reactive oxidative species and inflammasome in intestinal epithelial cells. |
| [8] |
Zhou S, Wang Z, Hao Y, An P, Luo J, et al. 2023. Dandelion polysaccharides ameliorate high-fat-diet-induced atherosclerosis in mice through antioxidant and anti-inflammatory capabilities. |
| [9] |
Wu Z, Zhang T, Ma X, Guo S, Zhou Q, et al. 2023. Recent advances in anti-inflammatory active components and action mechanisms of natural medicines. |
| [10] |
Gautam R, Jachak SM. 2009. Recent developments in anti-inflammatory natural products. |
| [11] |
Ambriz-Pérez DL, Leyva-López N, Gutierrez-Grijalva EP, Heredia JB. 2016. Phenolic compounds: natural alternative in inflammation treatment. A review. |
| [12] |
Kim HP, Son KH, Chang HW, Kang SS. 2004. Anti-inflammatory plant flavonoids and cellular action mechanisms. |
| [13] |
Serafini M, Peluso I, Raguzzini A. 2010. Flavonoids as anti-inflammatory agents. |
| [14] |
Zhang X, Xiong H, Li H, Cheng Y. 2014. Protective effect of taraxasterol against LPS-induced endotoxic shock by modulating inflammatory responses in mice. |
| [15] |
Huwait EA, Saddeek SY, Al-Massabi RF, Almowallad SJ, Pushparaj PN, et al. 2021. Antiatherogenic effects of quercetin in the THP-1 macrophage model in vitro, with insights into its signaling mechanisms using in silico analysis. |
| [16] |
Yoo H, Ku SK, Baek YD, Bae JS. 2014. Anti-inflammatory effects of rutin on HMGB1-induced inflammatory responses in vitro and in vivo. |
| [17] |
Wan Y, Xu L, Liu Z, Yang M, Jiang X, et al. 2019. Utilising network pharmacology to explore the underlying mechanism of Wumei Pill in treating pancreatic neoplasms. |
| [18] |
Sun Y, Yang J. 2019. A bioinformatics investigation into the pharmacological mechanisms of the effect of Fufang Danshen on pain based on methodologies of network pharmacology. |
| [19] |
Xiong Y, Yang Y, Xiong W, Yao Y, Wu H, et al. 2019. Network pharmacology-based research on the active component and mechanism of the antihepatoma effect of Rubia cordifolia L. |
| [20] |
Li W, Yuan G, Pan Y, Wang C, Chen H. 2017. Network pharmacology studies on the bioactive compounds and action mechanisms of natural products for the treatment of diabetes mellitus: a review. |
| [21] |
Kibble M, Saarinen N, Tang J, Wennerberg K, Mäkelä S, et al. 2015. Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products. |
| [22] |
Fang S, Dong L, Liu L, Guo J, Zhao L, et al. 2021. HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine. |
| [23] |
Ru J, Li P, Wang J, Zhou W, Li B, et al. 2014. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. |
| [24] |
Sherman BT, Huang DW, Tan Q, Guo Y, Bour S, et al. 2007. DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis. |
| [25] |
Kanehisa M, Furumichi M, Sato Y, Matsuura Y, Ishiguro-Watanabe M. 2025. KEGG: biological systems database as a model of the real world. |
| [26] |
Chanput W, Mes JJ, Wichers HJ. 2014. THP-1 cell line: an in vitro cell model for immune modulation approach. |
| [27] |
Kong F, Ye B, Lin L, Cai X, Huang W, et al. 2016. Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes. |
| [28] |
Ayele Y, Kim JA, Park E, Kim YJ, Retta N, et al. 2013. A methanol extract of Adansonia digitata L. leaves inhibits pro-inflammatory iNOS possibly via the inhibition of NF-κB activation. |
| [29] |
Ishibashi Y, Matsui T, Takeuchi M, Yamagishi S. 2012. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression. |
| [30] |
Ge X, Gu Y, Wang W, Guo W, Wang P, et al. 2024. Corynoline alleviates hepatic ischemia–reperfusion injury by inhibiting NLRP3 inflammasome activation through enhancing Nrf2/HO-1 signaling. |
| [31] |
Xiang R, Xiao X, Liu J, Guo Z, He H, et al. 2024. Protective effects of functional Nano-Selenium supplementation on spleen injury through regulation of p38 MAPK and NF-κB protein expression. |
| [32] |
Kleemann R, Verschuren L, Morrison M, Zadelaar S, van Erk MJ, et al. 2011. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. |
| [33] |
Lee ES, Park SH, Kim MS, Han SY, Kim HS, et al. 2012. Caffeic acid disturbs monocyte adhesion onto cultured endothelial cells stimulated by adipokine resistin. |
| [34] |
Prasad K, Mishra M. 2018. AGE−RAGE stress, stressors, and antistressors in health and disease. |
| [35] |
González I, Morales MA, Rojas A. 2020. Polyphenols and AGEs/RAGE axis trends and challenges. |
| [36] |
Schmidt AM, Yan SD, Wautier JL, Stern D. 1999. Activation of receptor for advanced glycation end products. |
| [37] |
Simm A, Caßelmann C, Schubert A, Hofmann S, Reimann A, et al. 2004. Age associated changes of AGE-receptor expression: RAGE upregulation is associated with human heart dysfunction. |
| [38] |
Alves M, Calegari VC, Cunha DA, Saad MJA, Velloso LA, et al. 2005. Increased expression of advanced glycation end-products and their receptor, and activation of nuclear factor kappa-B in lacrimal glands of diabetic rats. |
| [39] |
Jang DI, Lee AH, Shin HY, Song HR, Park JH, et al. 2021. The role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics. |
| [40] |
Matarazzo L, Hernandez Santana YE, Walsh PT, Fallon PG. 2022. The IL-1 cytokine family as custodians of barrier immunity. |
| [41] |
Bode JG, Ehlting C, Häussinger D. 2012. The macrophage response towards LPS and its control through the p38MAPK–STAT3 axis. |
| [42] |
Chen T, Zhang X, Zhu G, Liu H, Chen J, et al. 2020. Quercetin inhibits TNF-α induced HUVECs apoptosis and inflammation via downregulating NF-kB and AP-1 signaling pathway in vitro. |
| [43] |
Huang X, Xi Y, Pan Q, Mao Z, Zhang R, et al. 2018. Caffeic acid protects against IL-1β-induced inflammatory responses and cartilage degradation in articular chondrocytes. |
| [44] |
Jang EA, Han HJ, Tin TD, Cho E, Lee S, et al. 2023. The effect of caffeic acid phenethyl ester (CAPE) on phagocytic activity of septic neutrophil in vitro. |
| [45] |
Awwad O, Coperchini F, Pignatti P, Denegri M, Massara S, et al. 2018. The AMPK-activator AICAR in thyroid cancer: effects on CXCL8 secretion and on CXCL8-induced neoplastic cell migration. |
| [46] |
Maity S, Kinra M, Nampoothiri M, Arora D, Pai KSR, et al. 2022. Caffeic acid, a dietary polyphenol, as a promising candidate for combination therapy. |
| [47] |
Nakanishi K, Yanase E, Jang YP. 2010. Syntheses of antioxidant flavonoid derivatives. |